RFP
ENTA icon

Root Financial Partners’s Enanta Pharmaceuticals ENTA Stock Holding History

Root Financial Partners’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.49K Buy
+118
New +$1.58K ﹤0.01% 2440

Other funds holding ENTA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SSC
Spruce Street Capital New York $416M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Root Financial Partners's ENTA Position: Q1 2026 in Review

Root Financial Partners opened a new position in Enanta Pharmaceuticals (ENTA) in Q1 2026: 118 shares worth $1.49K. The stake represents ﹤0.01% of the portfolio and ranks #2440 among its holdings.

133 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.

  • Root Financial Partners held 118 shares of Enanta Pharmaceuticals worth $1.49K as of Q1 2026.
  • Enanta Pharmaceuticals was a new Root Financial Partners position in Q1 2026.
  • Enanta Pharmaceuticals made up ﹤0.01% of Root Financial Partners's portfolio in Q1 2026, its #2440 holding.
  • 133 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.

Based on Root Financial Partners's 13F filing for Q1 2026, filed 24 Apr 2026.